SCHEMBL31335948

SCHEMBL31335948

CC1Cc2ccc(Br)cc2CN1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 3/20 0.45
PNMT P11086 6/20 0.43
ADRA2A P08913 3/20 0.43
ADRA2B P18089 3/20 0.43
ADRA2C P18825 3/20 0.43
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
AKR1C3 P42330 1/20 0.38
ABHD6 Q9BV23 2/20 0.38
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSP90AA1 P07900 1/20 0.36
FAAH O00519 1/20 0.36
CARM1 Q86X55 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20425850 0.85 HSD17B3 (0.46) HSD17B3PNMTADRA2AADRA2BADRA2C
SCHEMBL29551110 0.85 HSD17B3 (0.46) HSD17B3PNMTADRA2AADRA2BADRA2C
SCHEMBL31335913 0.84 HSD17B3 (0.42) HSD17B3PNMTADRA2AADRA2BADRA2C
SCHEMBL2518371 0.84 HSD17B3 (0.42) HSD17B3PNMTADRA2AADRA2BADRA2C
SCHEMBL23327054 0.83 OPRK1 (0.46) OPRM1OPRD1OPRK1
SCHEMBL12280302 0.82 PTPN1 (0.47) HSD17B3ABHD6
SCHEMBL31335775 0.82 PTPN1 (0.47) HSD17B3ABHD6
SCHEMBL12279538 0.82 PTPN1 (0.47) HSD17B3ABHD6
SCHEMBL2996992 0.82 PTPN1 (0.47) HSD17B3ABHD6
SCHEMBL9849102 0.82 POLB (0.50) HSD17B3OPRM1OPRD1OPRK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO disclosed